[go: up one dir, main page]

AR026560A1 - Recubrimiento - Google Patents

Recubrimiento

Info

Publication number
AR026560A1
AR026560A1 ARP000106139A ARP000106139A AR026560A1 AR 026560 A1 AR026560 A1 AR 026560A1 AR P000106139 A ARP000106139 A AR P000106139A AR P000106139 A ARP000106139 A AR P000106139A AR 026560 A1 AR026560 A1 AR 026560A1
Authority
AR
Argentina
Prior art keywords
coating
starch
sugar
suspension
coated tablets
Prior art date
Application number
ARP000106139A
Other languages
English (en)
Original Assignee
Biochemie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3525424&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR026560(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biochemie Gmbh filed Critical Biochemie Gmbh
Publication of AR026560A1 publication Critical patent/AR026560A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Glanulating (AREA)

Abstract

Un proceso para el recubrimiento de nucleos de tabletas, comprendiendo este nucleo de tableta una cantidad efectiva de cuando menos un compuestofarmacéuticamente activo, el cual comprende rociar una solucion o suspension de recubrimiento que comprend e un azucar, o un almidon, o una mezcla de un azucary un almidon, sobre las tabletas o los nucleos de tabletas, con la condicion de que se excluyan agentes formadores de película en la solucion o suspension derecubrimiento, para obtener tabletas recu biertas, tales como tabletas recubiertas y las mezclas de recubrimiento correspondientes.
ARP000106139A 1999-11-23 2000-11-21 Recubrimiento AR026560A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0198899A AT500063A1 (de) 1999-11-23 1999-11-23 Beschichtete tablettenkerne

Publications (1)

Publication Number Publication Date
AR026560A1 true AR026560A1 (es) 2003-02-19

Family

ID=3525424

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000106139A AR026560A1 (es) 1999-11-23 2000-11-21 Recubrimiento

Country Status (29)

Country Link
US (1) US8652517B2 (es)
EP (1) EP1231903B1 (es)
JP (1) JP2003514848A (es)
KR (1) KR20020059771A (es)
CN (1) CN1391465A (es)
AR (1) AR026560A1 (es)
AT (2) AT500063A1 (es)
AU (1) AU776662B2 (es)
BR (1) BR0015449A (es)
CA (1) CA2387575A1 (es)
CO (1) CO5261638A1 (es)
CZ (1) CZ20021765A3 (es)
DE (1) DE60025536T2 (es)
EC (1) ECSP003781A (es)
ES (1) ES2255521T3 (es)
HK (1) HK1049786A1 (es)
HU (1) HUP0204072A3 (es)
IL (1) IL149189A0 (es)
MX (1) MXPA02005195A (es)
NO (1) NO20022362L (es)
NZ (1) NZ518524A (es)
PE (1) PE20011009A1 (es)
PL (1) PL354456A1 (es)
RU (1) RU2002116225A (es)
SK (1) SK6962002A3 (es)
TR (1) TR200201028T2 (es)
TW (1) TW579298B (es)
WO (1) WO2001037816A2 (es)
ZA (1) ZA200203654B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60205870T2 (de) * 2001-02-27 2006-06-29 Ranbaxy Laboratories, Ltd. Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
US20030072729A1 (en) * 2001-05-15 2003-04-17 Christopher Szymczak Simethicone as weight gain enhancer
GB2380936B (en) * 2001-10-18 2003-07-09 Reckitt Benckiser Healthcare Improvements in or relating to compositions
TW200404550A (en) * 2002-07-08 2004-04-01 Sankyo Co Cepharospolin formulation for oral use
JP4526247B2 (ja) * 2002-07-08 2010-08-18 第一三共株式会社 経口用セファロスポリン製剤
CN1681493A (zh) * 2002-07-19 2005-10-12 兰贝克赛实验室有限公司 掩味舒马曲坦片剂及其制备方法
KR20040011087A (ko) * 2002-07-27 2004-02-05 주식회사 씨티씨바이오 불쾌한 맛과 향을 차폐할 수 있는 록시스로마이신 과립의제조방법
KR100523082B1 (ko) * 2002-09-11 2005-10-20 (주)다산메디켐 쓴 맛이 은폐된 세푸록심악세틸 제제의 제약조성물 및 그의 제조방법
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
GB2407498B (en) * 2003-10-30 2008-06-11 Cipla Ltd Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient
GB0403628D0 (en) * 2004-02-18 2004-03-24 Arrow Group Ltd Compression-coated tablets and the manufacture thereof
PE20070077A1 (es) * 2005-06-10 2007-02-07 Takeda Pharmaceutical Comprimido con recubierta con azucar
WO2007049304A2 (en) * 2005-10-27 2007-05-03 Jubilant Organosys Limited Stable coated pharmaceutical formulation of olanzapine and process for preparing the same
CA2953964A1 (en) 2006-01-06 2007-07-19 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron
JPWO2007148772A1 (ja) * 2006-06-23 2009-11-19 塩野義製薬株式会社 マクロライド系抗生物質の糖類被覆製剤
WO2007148786A1 (ja) * 2006-06-23 2007-12-27 Takeda Pharmaceutical Company Limited 安定化された固形製剤
WO2008057058A1 (en) * 2006-11-10 2008-05-15 Nobel Ilac Sanayii Ve Ticaret As Oral pharmaceutical compositions
JP5248060B2 (ja) * 2007-08-17 2013-07-31 興和株式会社 シリコーンを配合した糖衣製剤およびその製造方法
DE202009007393U1 (de) 2009-02-25 2010-07-22 Sensient Food Colors Germany Gmbh Dragiermittel zum Dragieren von Arzneimitteln und Lebensmitteln
CN102266304B (zh) * 2010-06-04 2012-12-26 瑞阳制药有限公司 苯唑西林薄膜衣片的制备方法
JP5806490B2 (ja) * 2011-03-31 2015-11-10 エスエス製薬株式会社 フィルムコーティング用組成物
WO2013151516A1 (en) * 2012-04-04 2013-10-10 Mahmut Bilgic Film tablet formulations comprising cefuroxime axetil and clavulanic acid
EP2882423A1 (en) 2012-08-07 2015-06-17 Sandoz AG Uncoated tablet comprising granules including a -lactam antibiotic and highly dispersed silicone dioxide
JP2014227406A (ja) * 2013-05-27 2014-12-08 株式会社ウメケン 苦味生薬含有粒状物
JP6031730B2 (ja) * 2014-12-19 2016-11-24 株式会社東洋新薬 経口剤、経口剤の製造方法、経口固形剤のコーティング用組成物
CN108815130A (zh) * 2018-08-27 2018-11-16 邓倩 一种头孢泊肟酯药片及其生产工艺
FR3089756B1 (fr) * 2018-12-17 2021-02-19 Roquette Freres Formes solides dragéifiées présentant une stabilité améliorée
EP3766483A1 (en) 2019-07-19 2021-01-20 BioPharma Synergies, S. L. Orodispersible powder composition comprising a triptan
JP7698962B2 (ja) * 2021-03-19 2025-06-26 三栄源エフ・エフ・アイ株式会社 不快風味のマスキング方法

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB407919A (en) * 1932-06-24 1934-03-29 Ig Farbenindustrie Ag Improvements in or relating to the manufacture of shaped medicinal preparations
US3185628A (en) * 1960-03-18 1965-05-25 Nopco Chem Co Sunscreening dihydroxy-diphenylsulfone derivatives
US3185626A (en) * 1963-03-06 1965-05-25 Sterling Drug Inc Tablet coating method
US3361631A (en) * 1963-09-30 1968-01-02 Sandoz Ag Method of sugar coating pharmaceutical tablets
JPS4837815B1 (es) * 1970-09-25 1973-11-14 Yamanouchi Pharma Co Ltd
GB1318757A (en) * 1970-11-16 1973-05-31 Yamanouchi Pharma Co Ltd Method of sugar coating tablets
US3751277A (en) * 1971-03-24 1973-08-07 Dow Chemical Co Tablet coating process and composition
US3753767A (en) * 1971-08-02 1973-08-21 Colgate Palmolive Co Method of sugar-coating tablets
US4238510A (en) * 1979-02-21 1980-12-09 Life Savers, Inc. Sugarless coating for chewing gum and confections and method
JPS5850968B2 (ja) * 1979-04-12 1983-11-14 フロイント産業株式会社 糖衣の製法
DE2936040C2 (de) * 1979-09-06 1982-05-19 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Dragierverfahren und Mittel zur Durchführung des Verfahrens, bestehend im wesentlichen aus Saccharose, wenigstens einem weiteren Zucker und Wasser
JPH0126661B2 (es) * 1979-10-17 1989-05-24 Roquette Freres
JPS57134414A (en) * 1981-02-13 1982-08-19 Nikken Kagaku Kk Preparation of sugar-coated tablet
IT1214875B (it) * 1984-06-21 1990-01-18 Ferrero Spa Prodotto confettato e procedimento per la sua fabbricazione
US4643894A (en) 1984-07-24 1987-02-17 Colorcon, Inc. Maltodextrin coating
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
FR2580904B1 (fr) * 1985-04-30 1990-08-10 Roquette Freres Produit de confiserie ou pharmaceutique a revetement sans sucre obtenu par drageification dure et son procede de preparation.
JPS625910A (ja) * 1985-07-02 1987-01-12 Shin Etsu Chem Co Ltd 薄層糖衣錠の製造方法
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
CA1316110C (en) * 1987-02-27 1993-04-13 Peter Lloyd Oren Sustained release matrix formulations
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
DD273000A1 (de) * 1988-06-20 1989-11-01 Univ Halle Wittenberg Verfahren zur herstellung von ueberzuegen auf arzneiformen
GB9104890D0 (en) 1991-03-08 1991-04-24 Glaxo Group Ltd Compositions
US5224989A (en) * 1991-11-18 1993-07-06 Eva Likarova Film-forming dispersion for a protective coating of drug and food containing articles and objects
DE4236025A1 (de) 1992-10-24 1994-04-28 Merck Patent Gmbh Orale Arzneiformen
US5759577A (en) 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
US5547948A (en) 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
DE19503670C2 (de) * 1995-01-25 1997-07-31 Lichtwer Pharma Gmbh Dragiersuspension und Verfahren zur Herstellung der Dragees
US5882707A (en) * 1996-01-05 1999-03-16 Bpsi Holdings, Inc. Method of coating an edible substrate with sugar/syrup or sugarless solutions containing dry color concentrate
ES2226107T3 (es) * 1997-01-06 2005-03-16 Bpsi Holdings, Inc. Recubrimiento de pelicula, y compsiciones de recubrimientos de pelicula, a base de dextrina.
US6221402B1 (en) * 1997-11-20 2001-04-24 Pfizer Inc. Rapidly releasing and taste-masking pharmaceutical dosage form
NZ506928A (en) * 1998-04-02 2003-09-26 Genencor Int A coating comprising a modified starch, a modified cellulose and optionally a plasticiser
DE19826517B4 (de) 1998-06-15 2006-03-23 Baxter Healthcare S.A. Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette

Also Published As

Publication number Publication date
HUP0204072A2 (en) 2003-05-28
CA2387575A1 (en) 2001-05-31
DE60025536T2 (de) 2006-08-10
AU2358501A (en) 2001-06-04
PL354456A1 (en) 2004-01-12
IL149189A0 (en) 2002-11-10
HK1049786A1 (zh) 2003-05-30
JP2003514848A (ja) 2003-04-22
NO20022362L (no) 2002-07-11
NO20022362D0 (no) 2002-05-16
CO5261638A1 (es) 2003-03-31
MXPA02005195A (es) 2003-01-28
BR0015449A (pt) 2002-07-09
NZ518524A (en) 2004-04-30
ECSP003781A (es) 2002-04-23
US8652517B2 (en) 2014-02-18
CN1391465A (zh) 2003-01-15
AU776662B2 (en) 2004-09-16
WO2001037816A3 (en) 2001-11-29
CZ20021765A3 (cs) 2002-08-14
ES2255521T3 (es) 2006-07-01
RU2002116225A (ru) 2004-01-20
SK6962002A3 (en) 2002-10-08
TW579298B (en) 2004-03-11
WO2001037816A2 (en) 2001-05-31
PE20011009A1 (es) 2001-10-18
ATE315383T1 (de) 2006-02-15
KR20020059771A (ko) 2002-07-13
ZA200203654B (en) 2003-06-05
EP1231903A2 (en) 2002-08-21
DE60025536D1 (de) 2006-04-06
EP1231903B1 (en) 2006-01-11
HUP0204072A3 (en) 2004-06-28
AT500063A1 (de) 2005-10-15
TR200201028T2 (tr) 2002-10-21
US20060034917A1 (en) 2006-02-16

Similar Documents

Publication Publication Date Title
AR026560A1 (es) Recubrimiento
AR048456A2 (es) Composicion farmaceutica de topiramato
BR0013825A (pt) Formas de apresentação de tramadol
GT199900203A (es) Composiciones de celecoxib.
CO5590906A2 (es) Composiciones farmaceuticas que comprenden metformina y glibenclamida para el tratamiento de la diabetes mellitus tipo ii
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
TW200700406A (en) Novel thiophene derivatives
NO20071095L (no) Hittil ukjente tiofenderivater
TW200716591A (en) Novel thiophene derivatives
AR025428A1 (es) Formas de administracion de tramadol retardadas mediante un revestimiento que contiene la sustancia activa tramadol en forma de sacarinato de tramadol asicomo eventualmente otros excipientes
IT1289160B1 (it) Compressa farmaceutica completamente rivestita per il rilascio controllato di principi attivi che presentano problemi di
MXPA02007915A (es) Mediador de lipido activado por aspirina.
DK1644376T3 (da) Pyrrolo 3,4-C pyrazol-derivater, der er aktive som kinase-inhibitorer
TW200716552A (en) Novel thiophene derivatives
EE200000595A (et) Toimeaine viimine kandjamaatriksisse
ECSP066972A (es) Profármacos mutuos de glucosamina y glucosamina/anti-inflamatorio, composiciones, y métodos
TW200738670A (en) Novel thiophene derivatives
WO2009059701A3 (de) Retardtabletten mit hydromorphon
EP0630898A4 (en) MEDICINE FOR THROMBOZYTOPENIA.
WO2010030704A3 (en) Antibacterial aminoglycoside analogs
EP1864665A4 (en) IMMUNOSUPPRESSIVE AGENT AND ANTI-TUMOR AGENT COMPRISING A HETEROCYCLIC COMPOUND AS ACTIVE INGREDIENT
EP1508570A4 (en) NEW PHYSIOLOGICAL ACTIVE SUBSTANCES
IT1317075B1 (it) Compressa matrice che permette la liberazione prolungata ditrimetazidina dopo somministrazione per via orale.
AR024462A1 (es) Tabletas farmaceuticas
NI200900084A (es) Compuestos de pirazol y triazol sustituidos como inhibidores de ksp.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal